Intravesical Gemcitabine Therapy Cuts Bladder Cancer Recurrence
TUESDAY, May 8, 2018 -- Immediate post-resection intravesical installation of gemcitabine is associated with reduced recurrence over four years for patients with suspected low-grade non-muscle-invasive urothelial cancer, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2018 Category: Pharmaceuticals Source Type: news

USPSTF: Decision to Undergo PSA Screening Should Be Individual
TUESDAY, May 8, 2018 -- The U.S. Preventive Services Task Force (USPSTF) concludes that the decision to undergo periodic prostate-specific antigen (PSA) screening for prostate cancer should be an individual one for men aged 55 to 69 years. These... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Md. biotech to be acquired by New Jersey pharmaceutical goliath
Rockville-based BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical goliath Janssen Biotech Inc., a Johnson& Johnson company, in a deal worth up to $1.04 billion. Janssen, based in Titusville, New Jersey, will pay BeneVir $140 million in cash upon closing of the transaction, expected in the second quarter of this year, according to a company announcement. Additional contingent payments based on the achievement of certain… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 8, 2018 Category: American Health Authors: Sara Gilgore Source Type: news

10 New Genetic Tests Reach the Market Each Day 10 New Genetic Tests Reach the Market Each Day
Genetic test availability and spending are escalating rapidly, with prenatal tests and cancer risk tests leading the way.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 8, 2018 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Algorithm Helps Manage Fever
(MedPage Today) -- Pediatric cancer patients with non-neutropenic fever could benefit (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 8, 2018 Category: Hematology Source Type: news

Expert Panel Highlights Patient Choice for Prostate Cancer Screen
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 8, 2018 Category: Cancer & Oncology Tags: Oncology, Reproductive Medicine, Preventive Medicine, News, Source Type: news

Type 2 Diabetes Ups Risk of Renal Cancer in Women, but Not Men
Association strongest in patients with diabetes duration of five years or less (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 8, 2018 Category: Cancer & Oncology Tags: Endocrinology, Nephrology, Oncology, Journal, Source Type: news

Study: Uterine cancer survivors have greater risk of cardiovascular problems
Survivors of uterine cancer are more likely to face cardiovascular problems several years after treatment, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 8, 2018 Category: Consumer Health News Source Type: news

Prostate Cancer Screening Final Recommendation
The U.S. Preventive Services Task Force (USPSTF or Task Force) has reviewed the evidence on PSA-based screening for prostate cancer and published its final recommendation. The Task Force recommends men ages 55 to 69 make an individual decision about prostate cancer screening with their clinician. The Task Force recommends against routine screening for men age 70 and older. (Source: PHPartners.org)
Source: PHPartners.org - May 8, 2018 Category: International Medicine & Public Health Source Type: news

Could this new pill replace breast screening?
One in three women who undergo breast cancer treatment did not need to; their benign masses were mistaken as cancerous in scans. A new pill by the University of Michigan hopes to change that. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news

Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company BOCA RATON, Fla., May 8, 2018 -- (Healthcare Sales & Marketing Network) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device ... Devices, Oncology, Dermatology, Personnel Sensus Healthcare, superficial radiation therapy, skin cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2018 Category: Pharmaceuticals Source Type: news

Prostate cancer screening test is overused for older men, experts say
Overuse of the PSA test can lead to painful and unnecessary biopsies as well as over-diagnosis and over-treatmentAdult American men aged between 55 and 69 should balance the risks and benefits of prostate cancer screening carefully before getting tested, the United States Preventive Task Force (USPTF) has recommended. Men older than 70 should not receive routine tests.The recommendation, published in theJournal of the American Medical Association on Tuesday, specifically addresses a blood test called the prostate specific-antigen test, or PSA. The changed guidelines were first published about a year ago.Continue reading......
Source: Guardian Unlimited Science - May 8, 2018 Category: Science Authors: Jessica Glenza in New York Tags: Prostate cancer Health Cancer research Medical research Science Society Source Type: news

Grip strength ‘easy way’ of screening for long-term disease risk
Measuring the strength of someone ’s grip could be a cheap, easy and effective way of identifying people at high risk of a wide range of diseases including heart problems and cancer, a study suggests. (Source: Nursing Times)
Source: Nursing Times - May 8, 2018 Category: Nursing Source Type: news

Biomarker may help diagnose lung cancer earlier
High levels of a protein found in the bloodstreams of lung cancer patients may lead to a method of detecting the disease earlier, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 8, 2018 Category: Consumer Health News Source Type: news

Prostate cancer screening recommendations rolled back
Men between the ages of 55 and 69 -- particularly those at high-risk for prostate cancer -- should talk to their physicians about the pros and cons of prostate cancer screening, according to new guidelines released Tuesday. (Source: CNN.com - Health)
Source: CNN.com - Health - May 8, 2018 Category: Consumer Health News Source Type: news

Prostate cancer screening recommendations get rolled back by US task force
Men between the ages of 55 and 69 -- particularly those at high-risk for prostate cancer -- should talk to their physicians about the pros and cons of prostate cancer screening, according to new guidelines released Tuesday. (Source: CNN.com - Health)
Source: CNN.com - Health - May 8, 2018 Category: Consumer Health News Source Type: news

USPSTF Backtracks, Now Says PSA Test Is'Individual Decision'USPSTF Backtracks, Now Says PSA Test Is'Individual Decision '
Final US Preventive Services Task Force (USPSTF) recommendation statement emphasizes the need to inform patients of both the potential benefits and harms of PSA-based prostate cancer screening.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

USPSTF: Prostate Cancer Screening Is'Individual Decision'USPSTF: Prostate Cancer Screening Is'Individual Decision '
Final US Preventive Services Task Force (USPSTF) recommendation statement emphasizes the need to inform patients of both the potential benefits and harms of PSA-based prostate cancer screening.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Experts have new advice on prostate cancer screening. Here's why they put it back on the table
In a shift that puts early detection of prostate cancer back on the agenda of middle-aged men and their doctors, a federal panel of experts is recommending that men ages 55 to 69 weigh the potential harms and benefits of prostate cancer screening and judge whether getting tested feels right to... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - May 8, 2018 Category: Science Authors: Melissa Healy Source Type: news

Experts have new advice on prostate cancer screening. Here's why they put it back on the table
The U.S. Preventive Services Task Force is changing its advice to men about prostate cancer screening. In new guidelines, the task force now recommends that clinicians individualize PSA screening for men 55 to 69 who are interested in it after learning about the potential benefits and harms. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - May 8, 2018 Category: Science Authors: Melissa Healy Source Type: news

Glass of red wine a day slashes men's risk of prostate cancer
Researchers from the University of Vienna found that one glass of red wine a day slashes men's risk of prostate cancer by around 12 per cent. Yet the same amount of white raises the risk by 26 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news

Woman devastated to discover her mother has breast cancer
Amberley Kent, 24, from Peterborough, has had an 'awful' past year after undergoing treatment. But she was 'brought back to square one' when her mother Cathy was diagnosed. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news

Janssen Biotech acquires Maryland biotech company $1 billion
BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical giant Janssen Biotech Inc., a Johnson& Johnson company, in a deal worth up to $1.04 billion. Janssen, based in Titusville, New Jersey, will pay BeneVir $140 million in cash upon closing of the transaction, expected in the second quarter of this year, according to a company announcement. Additional contingent payments based on the achievement of certain milestones, including… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 8, 2018 Category: Biotechnology Authors: Sara Gilgore Source Type: news

Janssen Biotech acquires Maryland biotech company $1 billion
BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical giant Janssen Biotech Inc., a Johnson& Johnson company, in a deal worth up to $1.04 billion. Janssen, based in Titusville, New Jersey, will pay BeneVir $140 million in cash upon closing of the transaction, expected in the second quarter of this year, according to a company announcement. Additional contingent payments based on the achievement of certain milestones, including… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 8, 2018 Category: Health Management Authors: Sara Gilgore Source Type: news

The Deadly Viruses Being Used To Combat Incurable Cancers
Can devastating viruses such as Zika and Polio really provide new treatment options for people with currently incurable cancers? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 8, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Throat cancer warning - man’s earache turned out to be deadly tumour
CANCER symptoms vary depending on which part of the body is affected by a tumour. This man ’s earache turned out to be deadly throat cancer - are you at risk? (Source: Daily Express - Health)
Source: Daily Express - Health - May 8, 2018 Category: Consumer Health News Source Type: news

Scientific expert reaction to new Cochrane Review on HPV vaccine for cervical cancer prevention in girls and women
This study looks at a collection of studies looking at the benefit of HPV vaccines in reducing pre cervical cancer lesions.  HPV also causes many other serious cancers (especially head and neck).  In time, as more people have been vaccinated, we will see a reduction in all HPV cancers.  The HP V vaccine is one of a number of vaccines using virus like particles (VLPS) which have been shown to be very safe over the last 35 years. “The Cochrane library of reviews has a very rigorous assessment process of all their reviews. “The review only looked at cervical precancer (in women and girls),...
Source: Cochrane News and Events - May 8, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

The Case for Early Screening Mammography The Case for Early Screening Mammography
' Pennywise and pound foolish'screening guidelines put women under 50 at increased risk for delayed breast cancer diagnosis, say researchers.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 8, 2018 Category: Radiology Tags: Hematology-Oncology News Source Type: news

This Durham company is $20M richer
Durham ’s Heat Biologics (Nasdaq: HTBX) has banked $20.7 million in a public offering of common stock and warrants. The offering was substantially oversubscribed, says Jeff Wolf, founder and CEO of Heat, and positions the company “to achieve many critical milestones over the next five quarters.” “ I think that people are beginning to understand that the immune system has a very big role in combatting cancer, and we look at the immune system almost like an orchestra – where if you only have… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 8, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

This Durham company is $20M richer
Durham ’s Heat Biologics (Nasdaq: HTBX) has banked $20.7 million in a public offering of common stock and warrants. The offering was substantially oversubscribed, says Jeff Wolf, founder and CEO of Heat, and positions the company “to achieve many critical milestones over the next five quarters.” “ I think that people are beginning to understand that the immune system has a very big role in combatting cancer, and we look at the immune system almost like an orchestra – where if you only have… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 8, 2018 Category: Health Management Authors: Jennifer Henderson Source Type: news

California judge affirms ruling: Coffee needs cancer warning
His final ruling is a huge blow to the industry's efforts to dispel the notion that coffee is harmful (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 8, 2018 Category: Consumer Health News Source Type: news

Expert Panel Highlights Patient Choice for Prostate Cancer Screen
TUESDAY, May 8, 2018 -- More men could receive PSA blood tests for prostate cancer under revised guidelines released Tuesday by the nation's leading panel on preventive medicine. The U.S. Preventive Services Task Force (USPSTF) now recommends that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 8, 2018 Category: General Medicine Source Type: news

OncoSec to combine ImmunoPulse device with Merck ’ s immunotherapy in breast cancer trial
OncoSec Medical (NSDQ:ONCS) expanded its relationship with Merck (NYSE:MRK) today, announcing a deal to combine its ImmunoPulse IL-12 device with Merck’s anti-PD-1 therapy, Keytruda, in a Phase II trial of patients with triple negative breast cancer. The trial is slated to study the drug-device combination in patients with inoperable locally advanced or metastatic cancer who have failed at least one systemic chemotherapy or immunotherapy. Get the full story at our sister site, Drug Delivery Business News. The post OncoSec to combine ImmunoPulse device with Merck’s immunotherapy in breast cancer t...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Wall Street Beat Merck OncoSec Medical Source Type: news

Long-Term Cardiovascular Risk for Endometrial Cancer Survivors
TUESDAY, May 8, 2018 -- Endometrial cancer survivors have an elevated risk of various adverse long-term cardiovascular outcomes, according to a study published online May 8 in the Journal of the National Cancer Institute. Sean Soisson, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Type 2 Diabetes Ups Risk of Renal Cancer in Women, but Not Men
TUESDAY, May 8, 2018 -- Type 2 diabetes is independently associated with a greater risk of renal cell carcinoma (RCC) in women, but not in men, according to a study published online April 20 in Diabetes Care. Rebecca E. Graff, Sc.D., from Harvard... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Breast cancer survivors have increased risk of diabetes
A study, published in theJournal of Clinical Oncology, reports that women successfully treated with hormone therapy for breast cancer have a greater risk of developing diabetes. Medpage Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 8, 2018 Category: Endocrinology Source Type: news

Cancer-causing virus is 'off the charts' in parts of Australia
HTLV-1, which can cause leukemia and lymphoma, has infected more than 40 per cent of adults in isolated communities in central Australia, with indigenous people being the worst hit. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news

Sunburn warning: How much you should reapply suncream - Dr Chris reveals best factor
SUNBURN treatments include creams and aloe vera gel. To prevent the condition, you should apply suncream. But, how often should you top up on sun tan lotion? ITV This Morning's Dr Chris reveals the best factor for preventing skin cancer (Source: Daily Express - Health)
Source: Daily Express - Health - May 8, 2018 Category: Consumer Health News Source Type: news

Roswell Park lands $10M in research grants
The funding comes from a variety of federal funding sources and will address research in such areas as physiological stress and cancer, use of tobacco and e-cigarette products during pregnancy. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 8, 2018 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Ancient cancer-causing virus is 'off the charts' in parts of Australia
HTLV-1, which can cause leukemia and lymphoma, has infected more than 40 per cent of adults in isolated communities in central Australia, with indigenous people being the worst hit. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news

Bowel cancer: Prevent the condition with simple household exercises
BOWEL cancer symptoms include bleeding from your behind, unexplained weight loss and stomach pains. According to Cancer Research UK, more than half of all bowel cancer cases could have been prevented. You can reduce your risk by changing your diet and lifestyle. (Source: Daily Express - Health)
Source: Daily Express - Health - May 8, 2018 Category: Consumer Health News Source Type: news

FDA grants priority review to Roche's cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination with Avastin® (bevacizumab), paclitaxel and carboplatin (chemotherapy), for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: World Pharma News)
Source: World Pharma News - May 8, 2018 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

Md. biotech to be acquired by New Jersey pharmaceutical goliath
Rockville-based BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical goliath Janssen Biotech Inc., a Johnson& Johnson company, in a deal worth up to $1.04 billion. Janssen, based in Titusville, New Jersey, will pay BeneVir $140 million in cash upon closing of the transaction, expected in the second quarter of this year, according to a company announcement. Additional contingent payments based on the achievement of certain… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 8, 2018 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Mass. imaging spending, use higher than other states
The Massachusetts Health Policy Commission has released a report that finds...Read more on AuntMinnie.comRelated Reading: MITA: MedPAC offers no new proof of imaging overuse ACR 2016: Repeat head CT not always overutilization Is imaging use poised for expansion or contraction? Study links overuse of imaging for prostate, breast cancer Geographic variations don't necessarily signify imaging overuse (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2018 Category: Radiology Source Type: news

CT colonography finds more cancer in seniors
Colorectal cancer screening with CT colonography (CTC) had a higher cancer...Read more on AuntMinnie.comRelated Reading: Does colonoscopy top CTC for cancer screening? Insurance coverage for CTC boosts screening CMS declines to revisit CT colonography coverage Longer CTC screening interval found safe, cost-effective USPSTF greenlights CT colonography for screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2018 Category: Radiology Source Type: news

Medical News Today: Unlocking the secrets of a cancer-fighting flower
The Madagascar periwinkle produces a chemical that has long been used against cancer. Until now, no one knew how, making production slow and expensive. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 8, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche today announced that new data from its early and late-stage clinical studies, on more than 19 approved and investigational cancer medicines, will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from 1-5 June, in Chicago, IL, United States. More than 180 abstracts have been accepted across 13 cancer types, including two “late breakers” and 15 oral presentations. (Source: Roche Media News)
Source: Roche Media News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche today announced that new data from its early and late-stage clinical studies, on more than 19 approved and investigational cancer medicines, will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from 1-5 June, in Chicago, IL, United States. More than 180 abstracts have been accepted across 13 cancer types, including two “late breakers” and 15 oral presentations. (Source: Roche Investor Update)
Source: Roche Investor Update - May 8, 2018 Category: Pharmaceuticals Source Type: news

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche today announced that new data from its early and late-stage clinical studies, on more than 19 approved and investigational cancer medicines, will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from 1-5 June, in Chicago, IL, United States. More than 180 abstracts have been accepted across 13 cancer types, including two “late breakers” and 15 oral presentations. (Source: Roche Media News)
Source: Roche Media News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Huntsman Cancer Institute opens Center for HOPE
(Huntsman Cancer Institute) Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to fund a clinical trial researching new and effective approaches to reduce tobacco use. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news